UK Innovation & Science Seed Fund

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Ikarovec is a gene therapy company focused on developing early-stage assets for the treatment of common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, including dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By targeting these conditions, Ikarovec seeks to provide effective treatments that restore sight and prevent blindness in patients.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Aquark Technologies specializes in the development of compact cold-atom systems aimed at advancing quantum applications such as atomic clocks, sensors, and navigation systems. The company employs a unique laser geometry technique, stemming from over a decade of proprietary research at the University of Southampton, to miniaturize these systems to the size of a matchbox. This innovation enables the creation of plug-and-play quantum devices that offer portability and support the integration of quantum technologies into everyday life, paving the way for the next generation of quantum sensing and computing solutions.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

HonuWorx is a technology company specializing in autonomous systems designed to enhance the efficiency and sustainability of robotic operations. The company's innovative software platform utilizes an edge-cloud architecture to facilitate communication and control among geographically distributed stakeholders, enabling them to monitor and manage robotic systems even when they are beyond line-of-sight. HonuWorx develops subsea robotics that support unmanned marine operations, significantly reducing dependence on large, costly manned vessels. By integrating off-the-shelf technologies, the company promotes lean operations and minimizes travel needs for offshore work, thereby aiding industries in restoring, exploring, and sustainably commercializing ocean resources.

Adamo Foods is a UK-based food technology company focused on developing plant-based whole-cut meats through innovative fermentation techniques and mycelium. The company aims to produce sustainable alternatives to traditional meat products, utilizing precision fermentation to create functional meat proteins. By harnessing fungal mycelium, Adamo Foods offers consumers an efficient, sustainable, and ethical way to enjoy meat-like experiences without sacrificing taste or quality.

Wave Photonics is a company based in Cambridge, UK, that focuses on advancing integrated photonics design through computational techniques. It develops a platform aimed at optimizing product designs and facilitating smoother integration within the supply chain. This platform includes a software tool that predicts the performance and variability of photonic components based on specific fabrication processes, along with an optimizer that creates a component library tailored for different manufacturing foundries. By streamlining these processes, Wave Photonics enables businesses to enhance efficiency in the development and production of integrated photonics products, ultimately promoting wider adoption of these technologies.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

Presymptom Health is a medtech company that specializes in developing clinical decision support algorithms and diagnostic tests aimed at early illness detection. The company focuses on pre-symptomatic diagnostics, allowing for the identification of conditions such as sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health's innovations aim to enhance critical care outcomes and improve patient management. Through its portfolio of blood tests and algorithms, the company seeks to transform the way healthcare providers approach patient care, ultimately contributing to better health outcomes and potentially saving lives.

ExactTrak is a cybersecurity company focused on developing software aimed at protecting mobile data. Its solutions are embedded in various hardware products, including USB memory devices and laptops. The company provides a managed service that includes both software deployment and mobile data security services through a patented hardware device. This approach helps organizations prevent data loss and safeguard against human error, allowing them to comply with legal requirements and mitigate the risks of data protection violations, which can lead to fines and reputational harm. ExactTrak also has a development agreement with a major processor manufacturer to integrate its technology into future generations of professional processors.

HutanBio is a biotechnology company focused on producing sustainable biofuels derived from algae. The firm offers HBx bio-oil, characterized by its high energy density, low carbon footprint, and sulfur-free composition. By developing scalable algal farms, HutanBio provides a drop-in replacement fuel that serves clients across various sectors, including marine, land, and aviation. This approach enables these industries to reduce their emissions and comply with environmental regulations, promoting a transition to cleaner energy solutions.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

MitoRx Therapeutics is a biotechnology company that focuses on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company targets various conditions, including neuromuscular disorders, metabolic diseases, and dementia. By specializing in mitochondrial-protective therapies, MitoRx seeks to address the underlying causes of these challenging diseases. The company is committed to both developing treatments for rare indications and forming partnerships to tackle broader health issues. Through its efforts, MitoRx aims to enable healthcare professionals to halt the progression of conditions associated with dystrophy and neurodegeneration.

Laverock Therapeutics is focused on advancing gene silencing technology to create innovative programmable cell therapies. Their platform enables the engineering of next-generation allogeneic cell therapies that can adapt to both internal and external environmental signals. This capability allows for the development of induced pluripotent stem cell (iPSC)-derived products that offer enhanced efficacy, safety, and accessibility, addressing many of the challenges faced by traditional therapeutic methods. Through its pioneering approach, Laverock Therapeutics aims to facilitate significant advancements in the fields of medicine and biotechnology.

Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.

Laverock Therapeutics is focused on advancing gene silencing technology to create innovative programmable cell therapies. Their platform enables the engineering of next-generation allogeneic cell therapies that can adapt to both internal and external environmental signals. This capability allows for the development of induced pluripotent stem cell (iPSC)-derived products that offer enhanced efficacy, safety, and accessibility, addressing many of the challenges faced by traditional therapeutic methods. Through its pioneering approach, Laverock Therapeutics aims to facilitate significant advancements in the fields of medicine and biotechnology.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.

CHAIN Biotechnology Ltd. is a biotechnology company that specializes in developing and utilizing Clostridium bacteria for various applications, leveraging recent advancements in synthetic biology and automation to enhance fermentation processes. The company focuses on producing chiral chemicals, which are essential for a variety of products such as nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Among its key developments are 3-hydroxybutyrate, a versatile chiral molecule, and (R)-methyl-3HB, a precursor chemical for the glaucoma treatment dorzolamide. Additionally, CHAIN Biotechnology is exploring cost-effective fermentation methods using sugar as a substrate. The company's expertise encompasses microbiology, molecular biology tools, and microbial strain development. Founded in 2014 and headquartered in London, United Kingdom, CHAIN Biotechnology is also engaged in developing therapeutic compounds aimed at addressing chronic gut-related diseases through its innovative drug development platform.

NK:IO is a biotechnology company focused on advancing natural killer cell-mediated immunotherapy, particularly in the realm of cancer treatment. The company specializes in developing innovative cell therapies and small molecule therapeutics designed to enhance the effectiveness of cancer targeting for physicians. By leveraging cutting-edge research and technology, NK:IO aims to improve treatment outcomes for patients facing cancer.

Resurrect Bio is a plant biotechnology company that will improve the immune systems of crop species to revolutionize the agricultural industry.

HydRegen is a biotechnology company based in Oxford, United Kingdom, founded in 2020. The company specializes in developing bio-based manufacturing technologies aimed at producing clean and sustainable chemicals. Utilizing biocatalysis, HydRegen offers innovative solutions that enhance agility, speed, and predictability during the early stages of industrial research and development. This approach enables the chemicals and pharmaceutical sectors to efficiently validate their processes while meeting essential requirements related to cost, productivity, and reproducibility on a large scale.

Vitarka Therapeutics is a London-based company focused on developing medical technologies and solutions for various types of cancer. The company has created a targeted non-viral delivery platform aimed at intracellular targets in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage patients suffering from lung, colon, breast, and other cancers. By utilizing re-engineered pore-forming proteins for cell-specific targeting and facilitating the endosomal release of therapeutic cargo, Vitarka Therapeutics aims to provide cancer patients with renewed hope and the potential to lead more normal lives.

Silicon Microgravity Limited specializes in the development of advanced sensor devices tailored for the oil and gas sector. Founded in 2014 as a spin-out from Cambridge University, the company leverages sensor technology originally developed through a collaboration with BP. This technology enables the recording of gravity data at high sensitivities and seismic data at ultra-low frequencies, significantly enhancing the management of oil and gas reservoirs. By using microelectromechanical system sensors, Silicon Microgravity transforms the measurement of densities deep within reservoirs from boreholes. Additionally, its technology finds applications in navigation, guidance, and stabilization for various intelligent systems across commercial, industrial, and military sectors. The innovations provided by Silicon Microgravity aim to improve efficiency and reduce costs for clients while supporting their social, safety, and environmental objectives.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

Productive Machines specializes in software optimization for the machining industry, helping manufacturers enhance productivity and sustainability. The company utilizes a digital twin of the machining process, incorporating physics, mechanics, dynamics, distortion, and vibration data to simulate and test millions of parameters. This approach allows manufacturers to refine their CAM and Gcode, ultimately improving part quality and reducing cycle times. By addressing issues such as chatter vibrations and tooling costs, Productive Machines enables machining companies to achieve better surface finishes and dimensional accuracy, streamlining their operations and reducing costs. The company emerged as a spin-out from the UK Advanced Manufacturing Research Centre, reflecting its commitment to advancing manufacturing technologies.

SugaROx specializes in the development of biostimulants that enhance agricultural productivity and resilience. Its products are designed to assist farmers in maximizing output from each unit of land while improving the overall sustainability of crop production. By addressing challenges such as drought and other adverse weather conditions, SugaROx aims to empower farmers to increase their productivity, profitability, and efficiency in crop systems.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

MicrofluidX Ltd is a company focused on advancing cell bioprocessing for autologous cell and gene therapy manufacturing. Founded in 2018 and headquartered in London, United Kingdom, the company has developed an innovative microfluidic bioprocessing system that integrates various cell culture functions, including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting within a single, automated, closed system. This technology addresses challenges related to process control, scalability, and cost in cell bioprocessing, enabling biologists to efficiently conduct process development by exploring numerous cell culture conditions.

Silveray specializes in the development of affordable large-area direct conversion detectors for the X-ray imaging market. The company employs advanced technology that utilizes nanoparticle-based X-ray conversion materials, produced as semiconductor ink, which are then deposited onto a pixel backplane. This innovative approach enables high-performance X-ray imaging and generates an electrical current in response to detected X-ray photons. By focusing on sustainability and cost-effectiveness, Silveray aims to enhance imaging capabilities for healthcare and various industries.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

MitoRx Therapeutics is a biotechnology company that focuses on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company targets various conditions, including neuromuscular disorders, metabolic diseases, and dementia. By specializing in mitochondrial-protective therapies, MitoRx seeks to address the underlying causes of these challenging diseases. The company is committed to both developing treatments for rare indications and forming partnerships to tackle broader health issues. Through its efforts, MitoRx aims to enable healthcare professionals to halt the progression of conditions associated with dystrophy and neurodegeneration.

Q5D is an innovative company that specializes in automating the manufacture and assembly of wiring looms and harnesses across various industrial sectors. By developing advanced laser micromachining technology, Q5D streamlines the intricate process of connecting electrical components. This technology enhances global manufacturing capabilities, particularly in consumer goods, electronics, automotive, aerospace, and robotics. By enabling the direct addition of wires and printed electronics to product surfaces, Q5D improves quality, productivity, and functionality while reducing manufacturing costs. As a result, the company provides its clients with a significant advantage in achieving efficiency, resilience, and sustainability in their operations.

Atheras Analytics specializes in developing AI-based software tools delivered as a service, aimed at enhancing the design and operation of Ka-band and Q/V-band satellite networks. The company's software utilizes machine learning algorithms derived from a comprehensive database of satellite signal propagation time-series measurements and high-resolution data. This innovative approach helps satellite operators mitigate the impact of weather on network performance, thereby improving overall service availability. By optimizing the design of multi-gateway satellite networks, Atheras Analytics enables operators to achieve more efficient and cost-effective solutions in the satellite communication industry.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

NanoSyrinx is a biotechnology company focused on developing an innovative system for the targeted delivery of therapeutic proteins and peptides directly into the cytosol of cells. By employing synthetic biology techniques, the company aims to create a groundbreaking method for drug delivery that enhances the efficacy, safety, and cost-effectiveness of treatments in the biopharmaceutical sector. This novel approach allows for precise delivery of therapeutic agents, potentially improving treatment outcomes for patients by ensuring that the drugs reach their intended cellular targets.

AgPlus Diagnostics Ltd. is a company specializing in the development of a diagnostic platform technology aimed at providing quantitative point-of-care products for various clinical applications, including human and veterinary diagnostics. Established in 2009 and headquartered in Sharnbrook, United Kingdom, the company designs, manufactures, and supplies diagnostic tests and accompanying readers. AgPlus Diagnostics employs an electrochemical reader and measurement system that enables personalized healthcare by delivering rapid diagnostic results based on individual biomarker profiles. This technology allows healthcare providers to make critical treatment decisions in a matter of minutes, enhancing the efficiency of patient care.

Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, founded in 2011. The company has developed a diagnostic platform that utilizes linear dichroism (LD) technology for a variety of applications, including the detection of antibiotic resistance in infections and testing for bacteria that cause food spoilage. This innovative platform enables simultaneous measurement of multiple targets in a single sample, employing various molecular recognition methods. Additionally, Linear Diagnostics offers a handheld reader specifically designed to measure LD signals. The technology provides significant advantages over conventional methods, facilitating rapid point-of-care tests for infectious diseases and addressing challenges related to antibiotic resistance while aiming to reduce healthcare costs.

Solasta Bio specializes in the development of environmentally friendly agricultural products focused on crop protection. The company offers a range of biological pesticides and neuropeptide-based insect control solutions designed to address the challenges posed by pests, including those resistant to traditional synthetic chemicals. By providing effective natural alternatives, Solasta Bio aims to assist farmers in managing pest populations while enhancing crop production sustainably and safely. Its innovative approach aligns with the growing global demand for effective and eco-conscious agricultural practices.

NanoSyrinx is a biotechnology company focused on developing an innovative system for the targeted delivery of therapeutic proteins and peptides directly into the cytosol of cells. By employing synthetic biology techniques, the company aims to create a groundbreaking method for drug delivery that enhances the efficacy, safety, and cost-effectiveness of treatments in the biopharmaceutical sector. This novel approach allows for precise delivery of therapeutic agents, potentially improving treatment outcomes for patients by ensuring that the drugs reach their intended cellular targets.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

MicrofluidX Ltd is a company focused on advancing cell bioprocessing for autologous cell and gene therapy manufacturing. Founded in 2018 and headquartered in London, United Kingdom, the company has developed an innovative microfluidic bioprocessing system that integrates various cell culture functions, including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting within a single, automated, closed system. This technology addresses challenges related to process control, scalability, and cost in cell bioprocessing, enabling biologists to efficiently conduct process development by exploring numerous cell culture conditions.

Ikarovec is a gene therapy company focused on developing early-stage assets for the treatment of common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, including dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By targeting these conditions, Ikarovec seeks to provide effective treatments that restore sight and prevent blindness in patients.

Pencil Biosciences is focused on creating an innovative genome modulation platform that addresses the limitations of existing gene-editing technologies. By developing a programmable tool for genome modulation, the company aims to provide new therapeutic options for patients suffering from rare diseases. This technology is designed to have a broad impact, allowing medical professionals to navigate the complexities of gene editing more effectively. Through its advancements, Pencil Biosciences seeks to enhance the capabilities of gene-editing applications in the medical field.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

C-Major Medical is dedicated to addressing the persistent issue of needle stick injuries (NSIs) in medical environments. Despite significant efforts and legislation aimed at reducing these incidents, the frequency of NSIs has not declined sufficiently. To tackle this challenge, C-Major Medical develops innovative safety devices, including a syringe and blood collection system designed specifically to minimize the risk of NSIs and prevent contaminating aerosols. By promoting the safety of healthcare staff, the company's solutions aim to enhance practices in hospitals, clinics, and other medical settings, ultimately contributing to a safer working environment for medical practitioners.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Procarta Biosystems Ltd, founded in 2007 and based in Norwich, United Kingdom, develops innovative antibacterial therapies using a DNA-based platform. The company focuses on addressing the growing challenge of drug-resistant bacterial strains by offering a range of proprietary nanoparticles, collectively referred to as "snare." These nanoparticles facilitate the delivery of oligonucleotides targeting various bacterial pathogens, including MRSA, through both topical and intravenous solutions. Additionally, Procarta's therapies include a broad-spectrum treatment for Gram-negative infections, particularly those acquired in hospital settings, and a specific solution aimed at preventing the recurrence of Clostridium difficile infections. Originating as a spin-out from the John Innes Centre, Procarta has garnered early-stage investment and operates within the Norwich Research Park, contributing to advancements in antibiotic development for challenging infections.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Antiverse is an innovative antibody discovery company that aims to accelerate drug development through its advanced platform. By integrating structural biology, machine learning, and medicine, Antiverse provides solutions to predict antibody-antigen binding and identify potential antibody drug candidates for challenging targets. The company employs machine learning and cell-free protein synthesis to enhance the prediction of antibody affinity for specific antigen targets, allowing pharmaceutical companies and contract research organizations to expedite the antibody hit discovery process. Antiverse is committed to transforming drug development and improving patient outcomes.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

Cytoseek Limited, a spinout from the University of Bristol, develops innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Established in 2017 and based in Bristol, the company utilizes a novel cell membrane augmentation technology that enhances the functionality of cell therapies. This technology enables targeted tissue delivery and improves cell survivability, potentially increasing the efficacy of treatments. Cytoseek is currently conducting proof of principle studies to validate its approach and is actively seeking partnerships with other cell therapy companies to advance these therapies into clinical applications, ultimately striving to improve human health.

Glialign specializes in regenerative technologies aimed at enhancing peripheral nerve repair. The company is developing a novel cell therapy that serves as a living nerve growth guide, designed to replace traditional nerve grafts, which often require harvesting nerves from other body parts. Current treatments for peripheral nerve injuries are only effective in less than half of the cases, highlighting the need for more reliable solutions. Glialign's approach provides an off-the-shelf alternative, enabling healthcare providers to facilitate nerve regeneration and improve functional recovery for patients suffering from nerve injuries.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Atelerix Limited, based in Cambridge, United Kingdom, specializes in the storage and transportation of viable cells and tissues at room temperature. Founded in 2006, the company has developed a patented technology that utilizes alginate hydrogels to encapsulate biological products, protecting them from biochemical and physical damage during storage and shipping. This innovative approach eliminates the need for cryopreservation, making it easier for customers to use cells and assays immediately upon arrival without the risk of cytotoxicity or damage. Atelerix's technology enhances predictability and reliability in drug discovery models and cell therapies, allowing for the safe storage and transport of suspended and planted cells, as well as tissues and stem cells.

Procarta Biosystems Ltd, founded in 2007 and based in Norwich, United Kingdom, develops innovative antibacterial therapies using a DNA-based platform. The company focuses on addressing the growing challenge of drug-resistant bacterial strains by offering a range of proprietary nanoparticles, collectively referred to as "snare." These nanoparticles facilitate the delivery of oligonucleotides targeting various bacterial pathogens, including MRSA, through both topical and intravenous solutions. Additionally, Procarta's therapies include a broad-spectrum treatment for Gram-negative infections, particularly those acquired in hospital settings, and a specific solution aimed at preventing the recurrence of Clostridium difficile infections. Originating as a spin-out from the John Innes Centre, Procarta has garnered early-stage investment and operates within the Norwich Research Park, contributing to advancements in antibiotic development for challenging infections.

SFH Oxford Ltd. is a company based in Didcot, United Kingdom, that specializes in developing and marketing innovative healthcare products aimed at improving the treatment of venous leg ulcers. Founded in 2011, the company offers a range of products, including Graducheck, a sensor-based technology that enhances the application of compression bandages, and anatomical focus technology graduated compression socks designed to ensure appropriate compression levels. SFH Oxford also provides K-gel, a wound dressing. By focusing on optimizing care for patients with chronic wounds, the company's solutions aim to enhance healing rates and patient compliance while remaining cost-effective for healthcare systems. SFH Oxford's leadership team brings extensive experience in medical device technology and wound care, and the company is actively conducting clinical and field trials on additional products that show promising results in real-world applications.

C-Major Medical is dedicated to addressing the persistent issue of needle stick injuries (NSIs) in medical environments. Despite significant efforts and legislation aimed at reducing these incidents, the frequency of NSIs has not declined sufficiently. To tackle this challenge, C-Major Medical develops innovative safety devices, including a syringe and blood collection system designed specifically to minimize the risk of NSIs and prevent contaminating aerosols. By promoting the safety of healthcare staff, the company's solutions aim to enhance practices in hospitals, clinics, and other medical settings, ultimately contributing to a safer working environment for medical practitioners.

MyoDOPA is develops a novel therapeutic profile providing efficient treatment.

Camstech Ltd is an early-stage company focused on developing innovative biochemical sensing technologies aimed at enhancing point-of-care diagnostics. Established in 2014 and having graduated from the CERN Business Incubation Centre at Harwell Campus, the company is now located at the STFC’s Campus Technology Hub in Daresbury Laboratory. Camstech seeks to commercialize a unique sensing technology initially developed by Professor Pankaj Vadgama, targeting applications in life sciences, biotechnology, and medical diagnostics. The company is creating advanced electrodes equipped with electrochemical sensors, which offer significant advantages over traditional screen-printed electrodes, including improved stability and resistance to biofouling. This technology positions biotechnology firms to create tests for emerging biomarkers, facilitating more effective monitoring and diagnostics.

Cagen is a synthetic biology company.

Pireta Ltd is a company focused on developing and commercializing technology for smart textiles. Established in 2017 and based in Teddington, United Kingdom, Pireta has created a unique additive process that integrates conductivity and sensors into fabrics without altering their feel or performance. This innovative approach enables the production of textiles that can serve various functions, including communication, physiological monitoring, and tracking. Pireta's technology is applicable across multiple industries, such as military, emergency services, defense, fashion, athletics, healthcare, biosciences, and RFID tagging, facilitating the creation of wearable smart garments and electronic textiles.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Puraffinity Ltd, founded in 2015 and based in London, specializes in innovative water treatment and purification solutions. The company, which was previously known as Customem Ltd before rebranding in July 2019, has developed a sustainable bio-based adsorbent material designed to effectively remove challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry, Puraffinity's technology allows for the selective capture of micro-pollutants, including pesticides, pharmaceuticals, and hazardous chemicals such as per- and polyfluoroalkyl substances. This capability enables clients to comply with stringent wastewater regulations while contributing to the protection of local ecosystems. Puraffinity is committed to addressing pressing water quality challenges through environmentally sustainable practices.

Cytox Limited specializes in developing products and services aimed at diagnosing and treating neurodegenerative disorders, particularly Alzheimer's disease. The company has created a genetic-based blood test that assesses the risk and diagnosis of Alzheimer's in its early stages, addressing a critical need as the prevalence of the disease rises globally. Cytox's offerings include cellular and genetic assays for identifying cell cycle deficits in patients, along with biomarker and drug-screening services for pharmaceutical companies engaged in clinical trials. The company collaborates with Affymetrix, part of Thermo Fisher Scientific, to enhance its commercial testing capabilities. Founded in 2004 and headquartered in Birmingham, United Kingdom, with additional offices in Manchester and Oxford, Cytox serves pharmaceutical and biotechnology firms, as well as research laboratories involved in clinical research and drug development.

Tropic Biosciences specializes in developing high-performing commercial varieties of tropical crops, utilizing advanced non-GMO gene editing techniques. The company focuses on promoting cultivation efficiencies to address the increasing global food demand while enhancing grower wellbeing and consumer health. By significantly accelerating the breeding process, Tropic Biosciences aims to deliver genetic improvements that empower local farming communities to produce organic crops. Their commitment to sustainable agricultural practices reflects a broader goal of improving environmental outcomes.

Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, founded in 2011. The company has developed a diagnostic platform that utilizes linear dichroism (LD) technology for a variety of applications, including the detection of antibiotic resistance in infections and testing for bacteria that cause food spoilage. This innovative platform enables simultaneous measurement of multiple targets in a single sample, employing various molecular recognition methods. Additionally, Linear Diagnostics offers a handheld reader specifically designed to measure LD signals. The technology provides significant advantages over conventional methods, facilitating rapid point-of-care tests for infectious diseases and addressing challenges related to antibiotic resistance while aiming to reduce healthcare costs.

Nemesis Bioscience is a UK-based biopharmaceutical company focused on reviving the effectiveness of antimicrobial therapies compromised by rising microbial resistance. The company specializes in developing Nemesis Symbiotics, which aim to restore the functionality of existing antibiotics, curb the spread of resistance genes, and safeguard the efficacy of new antibiotics. This innovative technology is applicable across all classes of antibiotics, addressing various resistance mechanisms and bacterial strains. Additionally, Nemesis Bioscience explores other applications such as reducing the toxicity of chemotherapeutics, inactivating virulence factors, and enabling the in vivo synthesis of biofuels and therapeutics. The company has received recognition for its entrepreneurial efforts, including an award from King’s College, Cambridge, and has filed international patent applications for its inventions.

The Electrospinning Company Ltd. specializes in the design, development, and manufacturing of biomaterials for regenerative medical devices and 3D cell culture applications. Based in Didcot, United Kingdom, the company offers a range of products, including aligned fiber scaffolds, removable scaffold discs, and tissue culture plates with hanging inserts. These products are utilized in tissue engineering, regenerative medicine, and drug discovery research. Additionally, the company provides various services, such as scaffold design, sterilization protocol development, regulatory support, and manufacturing for clinical trials. The Electrospinning Company collaborates with academic research groups to create innovative nanofiber solutions that address industrial challenges and enhance medical functions. Founded in 2008, the company also sells its products online, making its advanced biomaterials accessible for in vitro and in vivo applications.

AgPlus Diagnostics Ltd. is a company specializing in the development of a diagnostic platform technology aimed at providing quantitative point-of-care products for various clinical applications, including human and veterinary diagnostics. Established in 2009 and headquartered in Sharnbrook, United Kingdom, the company designs, manufactures, and supplies diagnostic tests and accompanying readers. AgPlus Diagnostics employs an electrochemical reader and measurement system that enables personalized healthcare by delivering rapid diagnostic results based on individual biomarker profiles. This technology allows healthcare providers to make critical treatment decisions in a matter of minutes, enhancing the efficiency of patient care.

Keit Ltd. specializes in the design and manufacture of advanced spectrometers and related instruments that operate across a spectrum from ultraviolet to far infrared rays. Established in 2012 and based in Didcot, United Kingdom, the company focuses on innovative applications for its products, which include the measurement of signal levels, vibrations, and various substances in both gas and liquid forms. One of Keit's flagship products is the microFTS®, a compact and rugged Fourier Transform Infrared (FTIR) spectrometer originally developed for space applications. This device sets a new benchmark for real-time liquid-state analyses and serves industries such as pharmaceuticals, chemicals, oil and gas, and food and beverage, where performance in extreme environments is crucial.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, United Kingdom, founded in December 2015. The company specializes in developing high-performance gas sensing technology using Laser Dispersion Spectroscopy. MIRICO's innovative instruments are designed for trace gas analysis and provide precise, real-time measurements of gas emissions, even in challenging weather conditions. Its offerings include stable isotope analyzers for space exploration and advanced monitoring solutions for applications in environmental monitoring, geochemistry, medical diagnosis, and oil and gas exploration. Through autonomous and continuous monitoring capabilities, MIRICO enables industries to track emissions effectively and gain insights into their operations, contributing to efforts aimed at achieving net-zero emissions and enhancing productivity. The company emerged as a spin-out from the Laser Spectroscopy Group at the STFC Rutherford Appleton Laboratory and is located on the Harwell Science & Innovation Campus.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

Quethera Limited is a gene therapy company based in Canterbury, United Kingdom, founded in 2013. The company specializes in developing innovative treatments for glaucoma and other ophthalmic diseases, particularly aimed at reducing progressive visual loss associated with these conditions. Quethera collaborates with leading experts in the field of glaucoma to design and conduct clinical trials that evaluate the efficacy and safety of its novel therapies, especially for patients who experience accelerated visual field loss. With a strong foundation in gene therapeutic design and development, Quethera is advancing its research pipeline from preclinical testing into clinical development, striving to enhance treatment options for patients suffering from common blinding eye diseases. As of August 2018, Quethera operates as a subsidiary of Astellas Pharma Inc.

Oxford Space Systems Limited, founded in 2013 and based in Harwell, United Kingdom, specializes in the development, manufacture, and marketing of deployable hardware structures for space environments. The company focuses on creating innovative deployable antennas, panels, hinge systems, and composite linear boom systems, utilizing advanced design techniques such as origami and proprietary materials. These technologies aim to produce structures that are lighter, less complex, and more cost-effective than traditional alternatives, catering to the global satellite industry. Oxford Space Systems has gained recognition for its rapid product development, notably with its AstroTube Boom, which achieved successful deployment in under 30 months. The company has engaged in various co-development projects supported by the UK government, collaborating with leading European satellite manufacturers and securing commercial contracts in Asia and the US. With a growing team of professionals possessing extensive experience in the space sector, Oxford Space Systems operates from a custom facility at the Harwell Space Cluster, equipped to handle defense and security contracts.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

CHAIN Biotechnology Ltd. is a biotechnology company that specializes in developing and utilizing Clostridium bacteria for various applications, leveraging recent advancements in synthetic biology and automation to enhance fermentation processes. The company focuses on producing chiral chemicals, which are essential for a variety of products such as nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Among its key developments are 3-hydroxybutyrate, a versatile chiral molecule, and (R)-methyl-3HB, a precursor chemical for the glaucoma treatment dorzolamide. Additionally, CHAIN Biotechnology is exploring cost-effective fermentation methods using sugar as a substrate. The company's expertise encompasses microbiology, molecular biology tools, and microbial strain development. Founded in 2014 and headquartered in London, United Kingdom, CHAIN Biotechnology is also engaged in developing therapeutic compounds aimed at addressing chronic gut-related diseases through its innovative drug development platform.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. By offering a suite of features that can be utilized independently or collectively, NorthRow allows users to conduct thorough checks on individuals and companies, as well as verify identity documents. This capability aids in optimizing business processes, reducing risk, and ensuring compliance with regulatory standards. The platform streamlines onboarding processes and enhances client due diligence by continuously monitoring customer profiles for relevant changes, thereby proactively managing regulatory risks. By leveraging multiple data sources for authentication, NorthRow enables businesses to improve their customer experiences while effectively combating financial crime.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Spectral Edge is a technology company focused on developing advanced image processing and enhancement solutions. It utilizes patented image fusion technology combined with deep learning to improve the quality and visibility of images, particularly for individuals with color vision deficiencies. By leveraging the full spectrum of color, Spectral Edge's technology enables the display of multi-modal images that enhance detail and clarity without introducing artifacts. This innovation aims to benefit application developers and enhance the user experience across mass-market devices, allowing for richer and more accessible visual content.

Tokamak Energy Ltd is a private company based in Abingdon, United Kingdom, focused on the development of fusion power technology. Established in 2009, it specializes in creating compact fusion reactors known as spherical tokamaks, which offer a more efficient means of achieving high plasma pressure compared to traditional designs. The company's key products, the ST25 and ST40, utilize high-temperature superconductors and advanced materials to enhance plasma confinement and overall reactor performance. By leveraging decades of scientific research, Tokamak Energy aims to accelerate the commercial viability of fusion energy, positioning itself as a leader in the pursuit of affordable and sustainable energy solutions that contribute to global energy security while minimizing environmental impact.

Claresys Ltd. specializes in the development and supply of lens solutions tailored for covert surveillance applications. The company offers a range of products, including covert pinhole pan/tilt/zoom lenses designed for C mount 1/3” sensor cameras and miniature pinhole camera lenses. Additionally, Claresys customizes lenses for long-range surveillance in challenging environments, such as nuclear and high-temperature settings. Their optical technologies are versatile, suited for both close surveillance in buildings and vehicles as well as long-distance stake-outs. Claresys primarily serves clients in the defense, homeland security, and police sectors, distributing its products through a network that spans several countries, including the United Kingdom, the United States, Australia, and various nations in Europe. Established in 2007, the company is headquartered in Abingdon, United Kingdom.

NorthRow is a web-based platform designed to enhance risk, compliance, and anti-fraud decision-making for regulated businesses. By offering a suite of features that can be utilized independently or collectively, NorthRow allows users to conduct thorough checks on individuals and companies, as well as verify identity documents. This capability aids in optimizing business processes, reducing risk, and ensuring compliance with regulatory standards. The platform streamlines onboarding processes and enhances client due diligence by continuously monitoring customer profiles for relevant changes, thereby proactively managing regulatory risks. By leveraging multiple data sources for authentication, NorthRow enables businesses to improve their customer experiences while effectively combating financial crime.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutic products. Established in 2003, the company specializes in small-molecule inhibitors that target p300 and CBP proteins, as well as a deubiquitinase enzyme closely linked to prostate cancer. This enzyme modulates the androgen receptor pathway, which is critical in addressing resistance mechanisms encountered with existing prostate cancer treatments. CellCentric's therapies aim to treat various cancers, including castrate-resistant prostate cancer, lung cancer, bladder cancer, non-small cell lung cancer, breast cancer, and colon cancer. By targeting specific pathways and mechanisms, CellCentric seeks to provide effective treatment options for patients with challenging cancer types.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

SFH Oxford Ltd. is a company based in Didcot, United Kingdom, that specializes in developing and marketing innovative healthcare products aimed at improving the treatment of venous leg ulcers. Founded in 2011, the company offers a range of products, including Graducheck, a sensor-based technology that enhances the application of compression bandages, and anatomical focus technology graduated compression socks designed to ensure appropriate compression levels. SFH Oxford also provides K-gel, a wound dressing. By focusing on optimizing care for patients with chronic wounds, the company's solutions aim to enhance healing rates and patient compliance while remaining cost-effective for healthcare systems. SFH Oxford's leadership team brings extensive experience in medical device technology and wound care, and the company is actively conducting clinical and field trials on additional products that show promising results in real-world applications.

Tokamak Solutions UK Ltd. engages in providing technology for fusion neutron source to transmute nuclear waste. The company was founded in 2009 and is based in Abingdon, United Kingdom.